Trademark Overview
On Tuesday, December 23, 2025, a trademark application was filed for PANTHEON with the United States Patent and Trademark Office. The USPTO has given the PANTHEON trademark a serial number of 99562954. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 23, 2025. This trademark is owned by Pantheon Bio, Inc.. The PANTHEON trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Biotechnology research; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of biochemical, therapeutic, and pharmaceutical preparations; Research and development of biological computers for designing, developing, testing and manufacturing therapies for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Scientific and technological consultation services in the field of designing, developing, testing and manufacturing biochemical, therapeutic, and pharmaceutical preparations; Scientific and technological consultation services in the field of designing, developing, testing and manufacturing therapies for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Custom development of therapies and pharmaceutical and biopharmac...
Gene therapy pharmaceutical preparations; Pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; Biological preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations and gene therapy products in the nature of biological preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders